Browse > Article
http://dx.doi.org/10.3831/KPI.2016.19.029

The Current Status of New Antidiabetic Drugs  

Pemminati, Sudhakar (Department of Medical Pharmacology, American University of Antigua College of Medicine & Manipal University)
Millis, Richard Mark (Department of Medical Physiology, American University of Antigua College of Medicine)
Kamath, Ashwin (Department of Pharmacology, Kasturba Medical College, Manipal University)
Shenoy, Ashok Kudgi (Department of Pharmacology, Kasturba Medical College, Manipal University)
Gorantla, Vasavi Rakesh (Department of Behavioural Sciences and Neuroscience, AUA College of Medicine)
Publication Information
Journal of Pharmacopuncture / v.19, no.4, 2016 , pp. 291-292 More about this Journal
Keywords
lifestyle; multimodal treatment; metabolic syndrome;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhang Y, McCoy RG, Mason JE, Smith SA, Shah ND, Denton BT. Second-line agents for glycemic control for type 2 diabetes: are newer agents better?. Diabetes Care. 2014;37(5):1338-45.   DOI
2 Chowdhary M, Kabbani AA, Chhabra A. Canaglifloz-in-induced pancreatitis: a rare side effect of a new drug. Ther Clin Risk Manag. 2015;11:991-4.
3 Diabetes: facts and figures [internet]. Belgium: Inter-national Diabetes Federation; 2015 [cited 2016 Aug 14]. Available from: http://www.idf.org/about-diabetes/facts-figures.
4 Kabadi UM. Sulfonylurea glimepiride: a proven cost effective, safe and reliable war horse in combating hyperglycemia in type 2 diabetes. J Diabetes Mellitus. 2015;5(4):211-26.   DOI
5 Pemminati S, Millis RM, Kamath A, Shenoy AK, Gan-gachannaiah S. Are the newer antidiabetic agents worth the cost?. J Clin Diagn Res. 2016;10(3):DOI: 10.7860/JCDR/2016/17683.7384.   DOI
6 Pemminati S, Adhikari P, Pai MR, Pathak R. Metabolic syndrome among inmates of a 'home for aged' using IDF 2005 criteria. Nepal Med Coll J. 2009;11(1):31-3.
7 Pemminati S, Prabha Adhikari MR, Pathak R, Pai MR. Prevalence of metabolic syndrome (METS) using IDF 2005 guidelines in a semi urban south Indian (boloor diabetes study) population of Mangalore. J Assoc Physicians India. 2010;58:674-7.
8 Guettier JM, Georgopoulos A, Tsai MY, Radha V, Shan-thirani S, Deepa R, et al. Polymorphisms in the fatty ac-id-binding protein 2 and apolipotrotein C-III genes are associated with the metabolic syndrome and dyslipi-demia in a South Indian population. J Clin Endocrinol Metab. 2005;90(3):1705-11.   DOI